Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Positron Emission Tomography01:29

Positron Emission Tomography

4.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.2K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

112
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
112

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

European urology·2026
Same author

NETosis associates with human TB lung tissue destruction and disease pathogenesis.

EMBO molecular medicine·2026
Same author

Prognostic Value of PSMA PET-Derived Tumor Burden Stratification in Metastatic Hormone-Sensitive Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Recent advances and current landscape of software tools for image analysis and dosimetry in nuclear medicine.

EJNMMI physics·2026
Same author

Corrigendum to <Advances in Dosimetry and Imaging for <sup>203</sup>Pb and <sup>212</sup>Pb Radiotheranostics'> <[Semin NuclMed55:1011-1031/https://doi.org/10.1053/j.semnuclmed.2025.09.006]>.

Seminars in nuclear medicine·2026
Same author

Imaging of infection in Nephro-urology: A practical nuclear medicine-focused review.

Seminars in nuclear medicine·2026

相关实验视频

Updated: Jun 28, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

9.9K

在PSMA阿尔法治疗术的进步

Mariza Vorster1, Mike Sathekge2

  • 1Department of Nuclear Medicine at Inkosi Albert Luthuli Hospital, University of KwaZulu-Natal, KwaZulu-Natal, South Africa.

Seminars in nuclear medicine
|April 24, 2024
PubMed
概括

使用225Ac-PSMA的向阿尔法疗法对前列腺癌具有前景,提供更好的结果和克服抗性. 需要进一步的研究来优化这种先进治疗的患者选择,剂量和副作用管理.

更多相关视频

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.2K
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

170

相关实验视频

Last Updated: Jun 28, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

9.9K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.2K
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

170

科学领域:

  • 在瘤学瘤学.
  • 核医学就是核医学.
  • 辐射疗法 辐射疗法

背景情况:

  • 向性阿尔法疗法 (TAT) 是一种新的治疗方法.
  • 225Ac-PSMA已经成为治疗前列腺癌的阿尔法治疗药物的领先药物.
  • 之前的审查依赖于有限的数据;最近的证据提供了更强大的理解.

研究的目的:

  • 为提供前列腺癌中225Ac-PSMA的最新概述.
  • 综合最近的元分析和多中心研究的发现.
  • 探索TAT在末期治疗之外的更广泛应用.

主要方法:

  • 审查最近的元分析和多中心回顾性研究.
  • 关于225Ac-PSMA疗效和安全的新兴数据的综合.
  • 探索临床试验数据和病例报告.

主要成果:

  • 225Ac-PSMA在克服抗辐射和诱导DNA损伤方面表现出潜力.
  • 最近的研究证实了225Ac-PSMA在前列腺癌患者的安全性和有效性.
  • 新出现的证据支持在疾病进程的早期考虑TAT.

结论:

  • 225Ac-PSMA是一种有前途的针对性阿尔法治疗前列腺癌.
  • 关键的临床挑战包括患者选择,最佳剂量,以及管理诸如异口症之类的副作用.
  • 进一步的研究对于完善治疗方案和最大限度地提高临床效益至关重要.